mental health
Dr Michelle Funk of the Department of Mental Health and Substance Use, who led the development of the WHO guidance

Providing community-based mental health care that is respectful of human rights and recovery-focused has proven successful and cost-effective, according to a new report released by the World Health Organization

WHO’s new “Guidance on community mental health service: promoting person-centered and rights-based approaches”, released today, includes examples from countries including Brazil, India, Kenya, Myanmar, New Zealand, Norway, and the United Kingdom of community-based mental health services that have demonstrated good practices that are non-coercive, incorporate the community, and respect people’s legal capacity, or their right to make decisions about their treatment and life. 

“[These services] look more holistically at supporting people in their overall lives. [There are also] services that don’t tell people what to do but work in partnership with people, to find the best way forward for that person in their life,” Dr. Michelle Funk of the Department of Mental Health and Substance Use, who led the development of the guidance, told Health Policy Watch.  

The report reviews what is required in areas that include mental health law, policy and strategy, service delivery, financing, workforce development, and civil society in compliance with the Convention on the Rights of Persons (CRPD), adopted as the international human rights standards in 2006. 

Few Countries Meet CRPD Requirements; Majority of Mental Health Budget Towards Psychiatric Hospitals

Though an increasing number of countries have sought to reform their laws, policies, and services to mental health care, few countries have established the frameworks necessary to meet the requirements of the CRPD. 

“We see many of the services that are being provided are not helping people in the way that they want to be helped,” said Funk. 

Reports from around the world highlight severe human rights abuses and coercive practices that are still far too common for countries of all income levels. These include forced admission and forced treatment; manual, physical, and chemical restraint; unsanitary living conditions; physical and verbal abuse. 

The lack of compliance with the CRDP is “very challenging for many countries,” she added, attributing this to several reasons. 

There is still a stigma associated with mental health that leads people with psychosocial disabilities and mental health conditions to be perceived as incapable of making decisions for themselves. There is also the lack of overall investment in mental health services, with a focus instead towards institutionalization and specialized care. 

“Countries continue to invest in what they’ve been investing in.” 

According to WHO’s latest estimates, governments spend less than 2% of their budgets on mental health, with the majority of reported expenditure on mental health allocated to psychiatric hospitals. 

Good Mental Health Services Already Exist, Should Be Scaled-Up

Users and Survivors of Psychiatry in Kenya (USP-Kenya) – promotes and advocates for the rights of persons with psychosocial disabilities through peer support

Shifting the whole paradigm to community-based mental health service that respects human rights may be difficult, but there have been successful services that remain on the periphery and can demonstrate to policymakers and service providers that it is possible to achieve.

These services include crisis support, mental health services provided within general hospitals, outreach services, supported living approaches, and support provided by peer groups. 

“The services are available and functioning well in low-, middle-, and high-income countries are producing really good results. And they’re doing it at either a comparable cost or even less than the traditional mainstream services,” said Funk. 

While it is important to focus on services provided in a low-income context, she added, middle-income and high-income countries also have services that can be adapted and scaled-up by low- and middle-income countries. 

Funk emphasized the importance of learning from the principles of these services to create country-specific mental health services, whether it is a low-, middle-, or high-income country.  

Larger Investment in Mental Health Needed

During the COVID-19 pandemic there has been increased recognition of the importance of mental health

In addition to adapting and scaling up existing person-centered mental health services, there also must be a larger investment in mental health

Over the course of the COVID-19 pandemic, there has been increased recognition of the importance of mental health and how it is closely linked to what is happening around us and the psychosocial determinants of health.

Concluded Funk: “We cannot afford to just perpetuate the services we have already. If we’re going to have increased investment, we must change the way we invest that money in mental health – towards community mental services that respect and promote human rights.” 

Image Credits: USPKenya/Twitter, AMSA/Flickr.

WHO PAHO Regional Director Dr Carissa Etienne has called for vaccine access to be ramped up in the Americas to help curb the spread of COVID-19.

Although the pace of new COVID-19 infections is slowing down across North America, cases continue to rise in Latin America. Surges in COVID-related deaths and infections in some countries are even higher now than at any point during this pandemic, says the WHO Pan American Health Organization (PAHO).

Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths. Four of the five countries with the highest death counts in the world were located in the Americas. 

“This year has been worse than last year,” said PAHO Regional Director Carissa Etienne at a briefing on Wednesday. The emergence of new variants of the coronavirus has added new complexities to epidemiological surveillance, and access to COVID19 vaccines needs to be expedited, she added.

Countries in the Caribbean, such as Trinidad and Tobago, reported their largest-ever spike in COVID-19 infections and deaths over the past month. 

Panama, Guatemala, Argentina, Uruguay, and Chile have also reported a rise in new cases.

In contrast, in Mexico, Ecuador, Brazil, Peru, and Costa Rica, the rate of new cases was slowing down, along with key states in the United States and Mexico, as well as some provinces in Canada.  

Globally, Latin America has become the world’s COVID hotspot, with a new wave of rising COVID cases peaking at 300 cases per million people this past weekend. This is currently more than three times the number of new cases being seen by hard-hit India, five times that of Europe and six times higher than the global average. 

Though vaccines will eventually curb the spread of the virus, access to vaccines and necessary equipment furthers inequality between countries in the region. 

“[We are] seeing the emergence of two worlds. One is quickly returning to normal and another where recovery remains in the distant future, and the differences are stark,” said Etienne.  

Vaccination ‘Trickles Down’ Inequitably to High-Risk Countries 

The United States is the only country in the region where more than 40% of its population is fully vaccinated.  While a handful of Latin American countries, such as Argentina, Chile and Uruguay have managed to get first jabs into the arms of some 20- 58 % of their population, others lag far behind. For instance, Ecuador, Peru and Bolivia, have so far only managed to vaccinate only 3% of their populations.


Etienne also noted that the situation is “particularly acute” in Central America and the Caribbean. Just 2 million people have been fully vaccinated in Central America, and less than 3 million vaccinated in the Caribbean. 

Some countries like Guatemala, Trinidad and Tobago, and Honduras have yet to administer enough doses to protect just 1% of the population.

“The inequities in vaccination coverage are undeniable,” Etienne pointed out, adding that vaccine supply is concentrated in a few nations, while most of the world waits for doses to trickle down.

“Though COVID-19 vaccines are new, this story isn’t. Inequality has too often dictated who has the right to health. We can’t let this happen again.” 

Vaccine Access Needs to be Ramped Up in Region

PAHO Regional Director Carissa Etienne welcomed recent announcements of vaccine donations from the US as well as Spain, but urged other countries to donate surplus vaccine doses to Latin America and not hoard the life-saving vaccines in “warehouses” .

The PAHO Regional Director called for vaccine access to be ramped up in the Americas, as the countries at greatest risk were the ones where vaccines have been the slowest to arrive and where vulnerable populations have yet to be protected. 

The United States government has recently donated an initial 6 million doses to countries in Latin America. Spain has also donated 5 million doses to Latin America and the Caribbean. 

Canada has committed $CAD 50 million to expand vaccines in the Latin American region. 

Etienne hoped that other countries, particularly those with excess doses, and global financial institutions, will follow in the footsteps of these countries in order to protect 70% of the population in the region. 

Driving Down Transmission Despite Increased Travel Between and Within Countries 

Traveler screening for coronavirus at Bogota, Colombia Airport – UN News/Laura Quinones

In addition to ramping up vaccinations, Etienne urged the Americas to do “everything that we can to drive down transmission”.

Despite the skyrocketing numbers, people are steadily increasing their movement and travelling within and between countries, with Etienne urging the region’s population to make responsible decisions.

If current trends continue, the health, social, and economic disparities in our region will grow even larger and it will be years before we control this virus in the Americas,” she warned: “But by working together we can limit the spread of COVID-19 and we can move closer to a more equal world.”

Self-Sufficiency for Vaccine and Health Supply Manufacturing Needed

 

While vaccine donations from other countries will be beneficial in the ‘short term’, said Etienne, the only way to achieve supply security is when manufacturing capacity is expanded in Latin America and the Caribbean.

The trade imbalance for the pharmaceutical sector in the Americas is striking. In 2018, Latin America and the Caribbean imported 10 times more health technologies, pharmaceuticals, vaccines, and equipment and supplies than exported. 

“This inability to have sufficient production has made us more vulnerable during the pandemic,” said Etienne, though she added that the region does have the capabilities to expand its production and manufacturing. 

“We are not starting from scratch. Our region does have established capacity for manufacturing vaccines across several countries.” 

Scaled-up vaccine and equipment manufacturing was seen in diseases such as yellow fever, meningitis, and influenza.

The region also has strong regulatory networks, agencies, and harmonization, which are key to guarantee the quality and safety of vaccines, build production, and work towards self-sufficiency. 

Etienne advocated for investment from within the region, as well as support of international partners, in addressing the self-sufficiency of health technologies in the future. 

“It is only this long term investment that will ensure we have the vaccines needed to curb this pandemic, and [also to ensure] that we will have the necessary essential medicines [and sufficient equipment and supplies] to deal with a whole range of illnesses that threaten our population.”

Image Credits: WHO PAHO.

Demonstrators outside of the European Parliament just before a vote on a controversial proposal to waive IP related to COVID vaccines and treatments

The World Trade Organization’s TRIPS Council agreed on Wednesday to move ahead with a “text-based process” – effectively greenlighting negotiations over a proposal to waive intellectual property associated with COVID tests, treatments and vaccines, Geneva-based trade officials said. The move was  the latest in a series of incremental advances on the controversial initiative by India and South Africa.  

But the agreement reached by the TRIPS Council members Wednesday after a two-day meeting  does not mean that European Union bloc, also backed by the United Kingdom, Republic of Korea and Switzerland, have acceded to the proposal for a blanket waiver, other sources told Health Policy Watch. 

Rather, an alternative EU proposal – which has proposed alternative measures to expand medicines and vaccines production  – would remain on the table side by side with the waiver proposal as part of the overall negotiations, the sources said.   

The EU alternative calls for the better use of existing WTO measures permitting countries to issue “compulsory licenses” to manufacturers to produce needed health products that are still under patent, under the existing provisions of the WTO Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS).  It also calls upon IP holders to step up their issuance of “voluntary licenses” for COVID-related health products in short supply. 

That EU proposal has been under heavy fire from medicines access groups since it was published in early June – including the EU’s own European Parliament.  On Wednesday evening, Parliamentarians voted for a resolution effectively supporting the WTO IP waiver initiative by a one-vote majority.   

The amendment approved expressed “support for proactive, constructive and text-based negotiations for a temporary waiver of the WTO TRIPS Agreement, aiming to enhance global access to affordable COVID-19-related medical products and to address global production constraints and supply
shortages.”

EU Digital COVID Certificate Also Approved 

Earlier in the day, MEPs debated and finally approved, an initiative to establish a system for an EU Digital COVID Certificate, to facilitate travel within the European bloc of countries.  The certificate system will still need to be approved directly by European governments. 

India Wants Text-Based Negotiations to Conclude by end July  

Meanwhile, TRIPS Council members were reportedly set to resume informal talks about the waiver on 17 June.  A statement by India to the WTO meeting set forth a target for concluding the talks by end July. 

“We would like negotiations to begin after this formal meeting, i.e. by mid-June… Looking at the severity of the 2nd and 3rd wave hitting different parts of the world, we have no time to lose, we look at concluding these negotiations by the end of July,” India was reported as saying, adding that “we are in a race against time.  

Typically, TRIPS Council members would need to reach agreement by consensus on a final draft text before submitting it to the WTO General Council – which includes all member states – for a meeting in late July. 

India and South Africa submitted their first proposal for an IP waiver on COVID health products to the WTO TRIPS Council in October 2020. The proposal called for a waiver on all forms of IP associated with medicines, tests and vaccines, including not only patents, but also critical “trade secrets” and copyrights that would be needed to expand the complex processes of vaccine manufacturing. 

For the first few months, the initiative drew broad support only from low- and middle-income countries.  But it  picked up considerable steam after the United States swung its support behind a more limited waiver of IP-related to COVID vaccines. That shift came in a surprise announcement by US Trade Ambassador Katherine Tai in May, coinciding with the last TRIPS Council meeting

Following that, South Africa and India submitted an amended draft, which maintained the broad scope of their original proposal – but set a time limitation of three years for the initial phase of the waiver – after which it would be reviewed in light of the evolution of the COVID pandemic. 

Waiver Proposal Saw Lengthy TRIPS Council Debates 

This week’s two day TRIPS Council meeting,  presided over by Ambassador Dagfinn Sørli of Norway, saw an emerging centrist bloc, led by the United States, Australia, Canada, New Zealand, Brazil, Norway, China and Chinese Taipei (Taiwan), seek a middle ground between the 63 countries that are now supporting the South African/Indian initiative on the IP waiver – and opponents, led by the European Union. 

Sources said that the US called upon both sides to focus on practical actions that would be needed by the WTO body to rapidly scale up the supply and distribution of vaccines.  US support for engaging in a text-based discussion will “spur additional proposals or ideas to be put on the table,” the US representative was reportedly quoted as saying, suggesting that the South African and Indian revisions don’t go far enough yet towards a compromise. 

Moreover, IP issues can only be part of the WTO response to the pandemic – trade and other barriers that are limiting the free movement of vaccines, raw materials and equipment needed for the manufacture of those vaccines must also be addressed, the US-led bloc of delegates stressed.

In contrast, European Union representatives said that they were ready to commence a text-based discussion based on the EU proposal – which is to be further detailed in coming days – while discussing the waiver as well.  The EU-led proposal does move beyond current WTO TRIPS rules, the bloc members asserted, by waiving exisitng requirements that countries undertake lengthy negotiations with the rights holder of a vaccine patent – before issuing a compulsory license. 

 Turkey, Chile, Singapore, Russia, El Salvador, Hong Kong and Mexico reportedly took a wait-and-see attitude on the initiative, in discussions that saw some 48 delegations taking the floor.

US Reportedly Ready For Massive Vaccine Donations

At the same time the TRIPS Council talks were wrapping up,  however, United States President Joe Biden was reportedly preparing an announcement about a massive US donation of 500 million Pfizer vaccines – as part of a new agreement with the pharma company, the New York Times reported.

Citing unnamed sources, the Times said that the US had reached a deal with Pfizer to purchase the doses at cost, with the first 200 million doses to be distributed this year, and the next 300 million in 2021.

Biden hinted at the impending announcement in a brief press statement at Andrews Air Force base, just before boarding Air Force One headed to Cornwall, England, for a meeting with other G7 leaders.

Such a massive donation by the United States would be a game-changer for LMICs that have suffered massive shortfalls of vaccines – effectively reaching WHO’s recent target for developed countries to share 250 million doses by September. But it also might deflate some of the building pressures on WTO members to agree to a sweeping text on an IP waiver.

Asked if the US would come up with a “vaccine strategy for the world,” Biden replied saying, “I have one and I’ll be announcing it.”

Image Credits: Twitter @ABC, @Right2Cure .

Reeta Roy, President and CEO of the Mastercard Foundation

The Mastercard Foundation will spend US$ 1.3 billion over the next three years to help vaccinate 50 million Africans against COVID-19 and accelerate the continent’s economic recovery from the pandemic, one of the world’s biggest foundations has announced.

Tuesday’s announcement by the Foundation and the Africa Centres for Disease Control and Prevention(Africa CDC) comes less than a week after the World Health Organization’s Africa region called for an increase in vaccine dose sharing as it witnessed a resurgence of COVID-19 cases in southern and eastern African countries – some of which are also entering the chilly winter season now. 

It also comes amid growing global concerns over Covid-19 vaccine inequality – with WHO’s African Regional Office announcing on 3 June that only 0.54% of Africa’s 1.2 billion people have been fully vaccinated. The African Development Bank has warned that the COVID-19 pandemic could drive 39 million people into extreme poverty in 2021, and said that widespread vaccination is critical to the economic recovery of African countries.

Reeta Roy, President and CEO of the MasterCard Foundation said the Foundation’s new Saving Lives and Livelihoods initiative will also lay the groundwork for establishing more vaccine manufacturing capacity in Africa by focusing on human capacity development, and strengthening the Africa CDC.

Roy told journalists during a media briefing that the aim of the initiative is to ensure that “all lives are valued and Africa’s economic recovery is accelerated”. “Ensuring equitable access and delivery of vaccines across Africa is urgent,” she said.

Describing the new partnership as a “bold step towards establishing a New Public Health Order for Africa”, Africa CDC Director John Nkengasong said: “Ensuring inclusivity in vaccine access, and building Africa’s capacity to manufacture its own vaccines, is not just good for the continent, it’s the only sustainable path out of the pandemic and into a health-secure future.”

Africa’s Race To Economic Recovery and Vaccination Agenda

A $1.3-billion donation from the Mastercard Foundation will help vaccinate 50 million Africans over the next three years.

With billions of doses of COVID-19 vaccines administered globally, the reopening of several economies now hinge on expanded vaccine coverage to begin the journey towards economic recovery.

This is also expected to happen in Africa which however has been plagued by the dual impacts of vaccine inequality and vaccine hesitancy that could further prevent the continent from regaining the economic losses attributable to COVID-19.

For the first time in 25 years, Africa, in 2020, faced an economic recession and the African Development Bank warned that COVID-19 could reverse hard-won gains in poverty reduction over the past two decades and drive 39 million people into extreme poverty in 2021. It described widespread vaccination as critical to the economic recovery of African countries.

The Mastercard Foundation said the initiative was aligned with the African Union’s vaccination goal. While less than 2% of Africans have received at least one dose of the COVID vaccine, the AU aims to vaccinate 6 out of 10 Africans by 2022, this means reaching about 750 million Africans — roughly the continent’s entire adult population.

Strengthening Africa’s Public Health Institutions

In remarks at the launch, Paul Kagame, President of Rwanda, said the initiative will strengthen the continent’s public health institutions and help save lives.

“It is practical and immediate. Lives are going to be saved through the vaccines  that will be purchased. There is also a commitment to work directly with our public health institutions and make them strong, creative parallel systems have not been effective,” Kagame said.

The partnership, said Kagame, also puts Africa’s long-term vision to produce medicines and vaccines on the continent into consideration. “But we have to do our part with a sense of urgency and excellence,”  said Kagame, urging key players in Africa to do things differently and not “a business-as-usual” mindset.

Nkengasong said the new initiative will work in synergy with others to advance and expand vaccine access in Africa –  including the WHO co-sponsored COVAX vaccine facility and the African Union’s own COVID-19 African Vaccine Acquisition Task Team (AVATT), which has offered a continent-wide procurement and financial mechanisms for African countries purchasing their own vaccines. However, many countries have been reluctant to borrow funds to buy needed vaccine doses. 

Kagame again called on the global community to expand access to vaccines across Africa, noting that doses of vaccines available to Africa are only a small portion of the global supply. Nkengasong said the continent still needs to meet the financial costs to purchase, deliver, and administer vaccines remain significant. 

But he was confident in the continent’s ability to meet the vaccine goal which he said will be achieved with active involvement of governments, global funders, the private sector, and other key players including citizens’ acceptance of the vaccines when they become available. 

The move received wide applause from other leading African health influencers with former Liberian President Ellen Johnson Sirleaf calling it a ‘game changer’.

 

Voting on the UN High-Level Declaration on AIDS

Russia stunned the United Nations High Level Meeting on AIDS on Tuesday when it proposed a series of last-minute oral amendments to the meeting’s final political declaration – removing references to “rights”; the decriminalisation of sex work; and harm reduction in the context of the battle against HIV/AIDS.

The text of the final declaration had been negotiated over the past two months under the leadership of Australia’s Mich Fifield and Namibia’s Neville Gertze, and Gertze told the meeting that 73 changes had already been made to accommodate Russia’s concerns.

The declaration text was finally adopted, not by consensus but by a vote, after the vast majority of delegates rejected further last-minute amendments proposed by Russia at the meeting. The declaration was approved by 162 countries voting in favour and four against, with Belarus, Nicaragua and Syria siding with Russia.

However, after the vote, a number of countries that supported the declaration also made it clear that their support was qualified.  Countries including Bahrain, Egypt and Libya disassociated themselves in particular from references to “key populations” – those groups considered particularly vulnerable to HIV, including sex workers, men who have sex with men and injecting drug users.

They described such groups as being against their culture, while Russia described them as an affront to “family values”.

Meanwhile, a number of African countries including South Africa, Rwanda and Cameroon expressed disappointment that the declaration, which is meant to guide the next stages of the global campaign against HIV, had not been adopted by consensus at the High Level meeting.

Declaration ‘Does Not Measure Up’

However, the US was the most direct in its condemnation of Russia’s “new and hostile amendments” – as well as the compromises that had been made to get to the current declaration.

“The political declaration before us, put simply, does not measure up,” said the US delegate.

What started as a “strong, ambitious declaration” that was evidence- and science-based, has become a text that “lacks the ambition needed to meet the stated goals of this High-Level Meeting: ending inequalities and ending AIDS”, she said.

The main issue the US had with the declaration was how “national sovereignty” had been given prominence, enabling countries an escape from implementing various clauses because of “national context”.

“Comprehensive sexuality education, and the recognition of sexual orientation and gender identity are central to an effective HIV/ AIDS response,” stressed the US delegate.

“HIV prevention and treatment programmes that do not recognise the diversity of populations and their unique needs will not successfully stop HIV infection or ensure that all persons living with HIV AIDS have access to treatment.”

Delegates from the US, Canada and Portugal (on behalf of the European Union) also condemned Russia’s approach which scuppered weeks of sensitive negotiations.

Research findings, such as a study published just this week also underline the importance of sensitivity to sexual orientation and gender identity in the battle against HIV/AIDS. The study, led by Matthew Kavanagh, of the Global Health Policy and Politics Initiative at Georgetown University, found that countries that criminalise same-sex relationships, illicit drug use, and sex work have worse outcomes against HIV.

Kavanagh’s research found that “in countries with criminalised legal environments, a smaller portion of people living with HIV knew their HIV status and had suppressed virus compared to countries with less criminalising laws”.

Russia Opposed to Harm Reduction, ‘Key Populations’ and ‘Rights’

Russia opposed a number of clauses including harm reduction measures.

The clauses that particularly offended Russia included those related to “key populations”, harm reduction; and reference to a “rights-based” approach in combatting HIV/AIDS.

In particular, Russia had wanted to drop a clause that committed the global community to “urgent and transformative action to end the social, economic, racial and gender inequalities, restrictive and discriminatory laws, policies and practices, stigma and multiple and intersecting forms of discrimination, including based on HIV status, and human rights violations that perpetuate the global AIDS epidemic”.

In addition, Clause 28, was also viewed as unacceptable by Moscow. This expresses “deep concern about stigma, discrimination, violence, and restrictive and discriminatory laws and practices that target people living with, at risk of and affected by HIV”.

Clause 37 on countries’ lack of progress on “expanding harm reduction programmes” was also earmarked for deletion. 

Overall, Russia accused UNAIDS of abandoning it’s science-based approach in favour of a “rights-based approach” and asked that all such references to “rights-based” be removed. 

In addition, Russia sought to delete language committing countries to “eliminating HIV-related stigma and discrimination, and to respecting, protecting and fulfilling the human rights of people living with, at risk of and affected by HIV” and “reviewing and reforming restrictive legal and policy framework” that create barriers or reinforce stigma and discrimination was also unacceptable (Clause 65 A and B).

These clauses are in line with the Joint UN Programme on AIDS (UNAIDS) 2025 “10-10-10 targets”: Less than 10% of countries with punitive legal and policy environments; less than 10% of people living with HIV and key populations experiencing stigma and discrimination, and less than 10% of women, girls, people living with HIV and key populations experience gender inequality and violence.

AIDS is Not Over, Says UNAIDS Head

UNAIDS Executive Director Winnie Byanyima

UNAIDS Executive Director Winnie Byanyima, told the opening plenary: “AIDS is not over. It is one of the deadliest pandemics of modern times. Since the start of the pandemic, 77 and a half million people have been infected with HIV globally and we have lost nearly 35 million people to AIDS. An AIDS death every minute is an emergency.”

A number of countries have made good progress to eliminate new cases by 2030 – a goal set at the last UN High Level Meeting in 2016 – but the COVID-19 pandemic had undermined progress, she added.

“The evidence shows that when laws are strengthened to support gender equality, the rights of key populations and confront stigmatisation, countries have made greater progress in treatment and prevention programmes benefiting everyone,” added Byanyima. “We need to keep moving forward in our common journey away from harmful punitive, outdated, often colonial laws and from all forms of discrimination.”

Yana Panfilova, a 23-year-old woman who was born with HIV and is a member of GNP+ Global Network of People Living with HIV, also addressed the plenary.

“The AIDS response is still leaving millions behind: LGBTQ people, sex workers, people who use drugs, migrants and prisoners, teenagers, young people, women and children who also deserve an ordinary life with the same rights and dignity enjoyed the most people in this room,” said Panfilova.

“If we’re going to make a real change, these four things must become a reality. First one, comprehensive sexuality education in all schools in all countries. Second, psychological support, and peer support for every adolescent living with HIV and young key populations.

Third, the community needs HIV services to become the reality, not the exception. And the last one, finally, get an HIV vaccine.”

Food safety is closely bound to nutrition and food security. Traditional markets, as a central component of the supply chain, have the potential to provide affordable, accessible, and safe food to consumers globally.

While the COVID pandemic has highlighted the pathogen risks that can emerge from unsafe animal and food handling in traditional markets – those same markets are also sources of healthy, fresh food for billions of people around the world – healthier and fresher, in many cases, than what may be found on a supermarket shelf. 

Post-pandemic, traditional food markets need to be modernized and strengthened – so that they can fulfill their real potential in future food systems, said panellists at the event “Talking Food Safety” coinciding with World Food Safety Day

The event was hosted by EatSafe, a program funded by USAID, and led by the Global Alliance for Improved Nutrition (GAIN).

“Food safety, nutrition and food security are inextricably linked,” said Bonnie McClafferty, Director of Food Safety at GAIN and Chief of Party for USAID’s EatSafe. “Unsafe food creates a vicious cycle of disease and malnutrition.”

McClafferty was the moderator of a panel of experts on India, Nigeria and West Africa who explored the role of traditional markets in food systems – and how greater consumer and vendor awareness of food safety issues, along with stronger regulatory frameworks, could pave the way for a more vibrant future.  

Supporting traditional markets – in which food safety is well-assured – also supports food security, local farm production, and more sustainable agro ecosystems – as part of a “One Health” approach to food systems that WHO, the Food and Agriculture Organization, UN Environment, and other actors have committed to support as part of pandemic recovery. 

Many consumers globally rely on traditional markets for affordable, accessible, and nutrient-dense foods.

Nutrition & Food Safety Risks 

Over 600 million people fall ill and 420,000 people die every year from eating contaminated food. Children under the age of 5 are among the most vulnerable. Some 75% of foodborne illnesses are in Africa and Southeast Asia, panellists noted, citing the latest WHO data

The incidence of foodborne illnesses is 27 times higher in Africa as it is in Europe or North America – where countries often lack strong regulatory systems to control food safety from field to marketplace. 

Food safety risks occur when foods are not safely produced, stored, handled, or prepared; as a result they can contain harmful bacteria, viruses, toxins, parasites, as well as excessive pesticides and chemical residues used at farm sites, and even physical or mechanical contaminants, like shards of plastic, metal or glass from damaged packaging or processes. Any one of these hazards can result in illness or injury, as well as death. 

And such risks are not confined to traditional markets, panellists stressed. They can also be present in fresh or packaged foods on sale at supermarkets as well. So what is needed is a new approach to food safety, and to marketplaces overall. 

Until the eruption of SARS-CoV2, very little public or policymaker attention was accorded to food safety risks generally, or traditional markets more specifically.  However, the emergence of the virus around a Chinese traditional market in Wuhan, heightened public awareness, as well as policymaker sensitivities.  A WHO-convened team of scientists recently concluded that the virus “very likely” emerged from human exposure to infected wild animals or meat somewhere along the traditional market food production or supply chain – although other critics say the virus also could have escaped from a nearby laboratory. Whatever the final verdict over SARS-CoV2, however, most experts agree that the pandemic has created a milestone moment for addressing some of the bigger, and more systemic issues around food safety – and traditional marketplaces.  

Wuhan’s Huanan seafood market that has been closed since early 2020 after one of the first clusters of COVID-19 cases were detected there.

The COVID-19 pandemic and the accompanying public health measures also disrupted delicate supply chains, access to food and sufficient nutrition, and the agricultural industry. Approximately 124 million more people were pushed into long-lasting poverty and hunger in 2020, according to a recent fact sheet by USAID’s “Feed the Future” initiative on global hunger and food security. 

The pandemic also changed the behaviour of both customers and vendors vis a vis traditional markets, according to research conducted by EatSafe between September and December 2020 in Nigeria, Kenya and Bangladesh, coordinated by McClafferty. 

Some changes were positive – others less so. 

On the one hand, more handwashing and sanitation stations were installed in markets, measures welcomed by consumers and vendors alike. Both shoppers and vendors began to pay more attention to hand hygiene, masking and social distances, which helped to control food safety risks as well as COVID infection spread.  

But across all three countries, consumers frequented markets less – affecting businesses and sales, the study found.  And in places like India, with a strong digital economy, the pandemic also seems to have accelerated a trend among younger shoppers away from fresh food markets to more online food purchases – which may also tip the balance to consumer reliance on more processed foods. Such trends, over the long-term, do not bode as well for the future of fresh food marketplaces, nutrition or health.  

“We at GAIN are concerned about that change in the diet, what are they turning to if they’re turning away from perishable foods. It’s very important that the [food] basket remains nutritious,” said McClafferty. 

Bonnie McClafferty, Director of Food Safety at GAIN and Chief of Party for USAID’s EatSafe.

Rather than abandoning markets, which play such a positive role in fresh food systems, what is really needed is greater awareness of food safety as a neglected public health problem – and measures to address shortcomings, said McClafferty and other panellists. 

“It’s ridiculous to think about shutting these [markets] down, they’re not going anywhere,” said McClafferty. “We need to strengthen them, we need to modernize them,…they need to be in demand.”

Traditional Markets – Hubs for “Nutrient Dense” Foods 

By their very nature, traditional markets provide ready access to healthy and affordable, albeit perishable, fresh foods that play critical roles in food security and nutrition. For example, in Nigeria, traditional and informal markets account for 70% of the entire food landscape and drive the local economy. 

Particularly in low- and middle-income countries, many consumers rely on traditional markets to purchase the most important, nutrient-dense foods in their diets, such as animal-sourced foods as well as fresh fruits and vegetables, nuts, and legumes.

Vegetable seller at Gosa Market in Abuja, Nigeria. Traditional markets provide access to healthy, fresh foods that play critical roles in feeding individuals and households globally.

But such markets, located in public venues and comprising dozens or hundreds of individual vendors, often fall through the net of government food safety standards and regulations, which in many LMICS may be weak or poorly enforced. And the rules that exist may not be enforced to the same degree in a marketplace as they are in a supermarket, which is under a single roof and controlled by a single corporate entity.  

The infrastructure of traditional markets, provided by government authorities or vendors’ associations, may also be of poor quality. Good storage facilities for products are often lacking, including no concrete flooring, no access to water for wash stations, and vendor stalls exposed to the elements, hot or cold, rainy or humid.  

Vendors and Consumers Lack Knowledge and Tools

Against this landscape, both vendors and consumers often lack the knowledge and tools to ensure food safety, said Mohamed Nasser, West Africa’s Regional Advisor for Food Safety and Quality Assurance at the World Food Programme (WFP). 

Better training for market vendors in food hygiene, safe food preservation and prevention of waste are all important measures essential to establishing and maintaining safer traditional markets, Nasser said. Other measures include raising food safety awareness among market workers and customers, and better enforcement of regulations. 

Training market vendors on food hygiene, safety, and preservation could lead to improvements in food safety in traditional markets, said the panellists on Monday.

The education of consumers, particularly children and parents, on food safety practices is essential because consumer demands can shift the behaviour of vendors and marketplaces, added Priya Prakash, campaign lead at the NGO Act4Food in New Delhi, India. 

“There needs to be a consumer campaign…that enables and empowers people to make better decisions” about food purchases and hygiene with food in the home, said Prakash.

“The consumer is central to food safety because it’s a demand and supply issue: if consumers begin to push for a cleaner and safer product, vendors are going to respond positively,” added Professor Olugbenga Ben Ogunmoyela, Executive Director of Consumer Advocacy for Food Safety and Nutrition Initiative in Lagos, Nigeria.

Key practices, he noted, include frequent cleaning and disinfection of work surfaces, preventing direct contact between shoppers, live animals and contaminated surfaces, and complying with personal hygiene practices. 

Improving Hygiene Practices 

Despite the devastation COVID-19 has caused, including to food market cultures, hygiene practices that were strengthened and enforced as part of COVID-19 responses have improved food safety in traditional markets, panellists agreed:

“One of the positive points of COVID-19 actually is just to bring back the basic hygiene requirements to be implemented…This is something basic for any traditional market,” said Nasser. 

His comments were based on findings from the biweekly consumer and vendor surveys conducted by GAIN in traditional markets of Bangladesh, Kenya, and Nigeria across the autumn and winter of 2020 – inputs that contributed to the broader USAID-supported study, soon to be published.  

According to those surveys, all three countries saw the implementation of at least some COVID safety measures, such as social distancing, wearing of face masks, hand washing or sanitising, and temperature checks upon entering the market.

The enforcement of the COVID rules, however, varied, with 85% of consumers in Kenya witnessing a strong investment in COVID protocols in marketplaces, as compared to only 35% of consumers in Bangladesh.

Some 80% of vendors surveyed in Kenya in January 2021, also reported a decrease in the number of customers over the previous nine months. In all three cases, consumers reduced their frequency of shopping in the market and avoided peak shopping hours. Decreased sales and customers also were reported by two-thirds of Nigerian vendors, although only 35% reported difficulties in accessing products to sell, while 42% reported difficulties in transporting goods, during the pandemic.

COVID-19 regulations, such as social distancing, wearing of face masks, hand washing or sanitising, and temperature checks upon entering the market, have been implemented to varying degrees across the three countries surveyed.

Sustaining Food Safety Measures Post-Pandemic

Key concerns about shopping in the market, as reported by consumers in Nigeria, included the fear of contracting COVID-19 (70%), food unavailability (34%), and the inconvenience of taking protective measures (32%).

Despite their inconvenience, significant numbers of consumers still welcomed the new safety and hygiene measures. In Bangladesh, some 46.2% of consumers saw the disinfection of marketplaces as the most useful COVID measure implemented, while 57.5% of vendors considered mask mandates to be the most effective. 

As pandemic fears wane, a major concern of panelists is whether newly adopted safety and hygiene measures can be maintained.

“I’m happy to have [basic safety measures] everywhere and applied by everybody, but at the same time, this is basic and should be continued. It’s nothing related to COVID-19, it’s something related to the fact that we need to ensure the safety of the food,” said Nasser. 

Already in some cases pandemic fatigue seems to be setting in, with vendors and customers abandoning the masks and gloves and reverting back to their original purchasing practices. 

Improving awareness and education will be important to sustain the improvement to food safety brought by COVID, the panellists concluded.

Despite the shortcomings in the COVID response, “we can take quite a few things from this particular experience to strengthen our traditional markets,” observed Ogunmoyela. Those lessons include ensuring that governments provide basic infrastructure support and guidelines so that basic safety standards can be met.

“We have to look at how to change attitudes through messaging that will go directly to both consumers and vendors at the market centres,” he added, saying: “The radio jingle is a very effective tool in this environment, and even infographics…that as people are approaching these markets, they know the do’s and don’ts.” 

Professor Olugbenga Ben Ogunmoyela, Executive Director of Consumer Advocacy for Food Safety and Nutrition Initiative in Lagos, Nigeria

The Case of India 

A strong shift away from markets and to online food orders has been particularly evident in India, and among younger generations – who have made use of new digital apps to order food deliveries – rather than venturing out to marketplaces where they feared being infected with COVID. 

“The process of going to a traditional market has broken down and now the distance from the consumer to the traditional market has started to increase,” said Prakash. Foods on sale in the traditional markets are often perceived as less sanitary than supermarkets, she added, even though that may not at all be the case. 

“We need to understand that the interaction and relationship that the younger generation will have with traditional markets will probably not be the same and it might have to change,” said Prakash. 

During the pandemic, “the way commerce is done has fundamentally changed for a lot of people,” she observes. People who never had a bank account set up digital accounts online, and moved to using digital money, which has now become central to the way in which money is exchanged. 

The digital transformation also was encouraged by the Indian government, which created apps that were required for people to register for vaccinations and to enter and exit certain venues, as part of surveillance and contact tracing efforts. 

“A large chunk of the population has started operating in this way in a very accelerated, unprecedented span of time,” Prakash said. Now, she says, traditional markets need to enter digital age as well – in order to remain vibrant centers of commerce post-COVID. 

Priya Prakash, Campaign Lead at #ACT4FOOD #ACT4CHANGE in New Delhi, India.

“The first basic thing that traditional markets can empower themselves with is the entire concept of digital money and transactions,” said Prakash.

“The whole concept of cash being given, which was a typical operating principle in the traditional markets, is changing rapidly. We need to introduce technology as a means to try to connect and [put] these traditional markets on the map for younger generations,” said Prakash.

“There might be a different way that [traditional markets] interact with consumers, with businesses, with technology companies, but traditional markets will always be at the heart of any food system. Going forward, there will be a transition where a lot of these farmers, a lot of these vendors will be empowered enough to sell directly online or represent themselves directly online,” said Prakash. 

“That is going to take a long period of time…[but] we’re looking at this decade of technology transformation…and I feel like that’s the future direction.” 

Updating and Transforming Traditional Market Design

But for the billions of consumers who will also continue to frequent markets in person, new effort also need to be invested in upgrading and modernizing markets’ physical facilities to ensure their safe design, the panellists emphasised. 

The markets “need to be reshaped, we need to build nutrition and food safety education into the system, we need to identify the critical needs and priorities across the landscape, and ensure that policies actually…embrace these markets,” said Ogunmoyela. 

Much closer attention to the details of the physical layout, facilities and organisation of marketplaces can provide the basis for promoting safer and healthier food and reducing the risk of transmission of foodborne and zoonotic disease. 

Greater investment is needed to expand on basic infrastructure in traditional markets and improve on the layout to reduce the risk of transmission of foodborne and zoonotic diseases.

Governments need to invest in implementing basic infrastructure, including an adequate water supplies for cleaning, water drainage systems, and toilets with hand-washing facilities. 

In addition, any market stalls or cages holding live animals, which are high risk areas for the transmission of pathogens, should be located far away from consumers – with the slaughtering process carried out in separate facilities, the panelists stressed. Such measures also have been the focus of new WHO guidance for traditional marketplaces.

Architects and urban designers can become critical intervenors in traditional markets – insofar as improving market design is critical to better food safety. Key measures should include “the use of better spacing, less crowding, [and] better traffic flow,” said McClafferty. 

While stronger regulatory frameworks also are key, consultations with consumers and vendors are also critical before new regulations are put in place, so as to gain a greater understanding of real market conditions, and ensure the uptake of any new rules and policies.  

“Food safety best practices should be customized based on the situation of each group,” said Nasser. “It is not something you can put in [a single set of] guidelines and it will be applicable everywhere in the world.”

Mohamed Nasser, Regional Advisor for Food Safety and Quality Assurance at the World Food Programme (WFP) in Dakar, Senegal.

Transforming Agri-Food Systems 

Rediscovering the value of traditional markets sits within a wider picture on the food chain – facing a wide range of challenges. 

At farm level, pesticide and bacterial contamination still need to be addressed in order to assure that food reaching the marketplace is healthy and safe. As a result, efforts to change behaviours should also be focused on the small food producers that supply the markets – farmers, fishermen, and butchers – to ensure that they reduce their use of pesticides and other potential chemical contaminants in all stages of the food production cycle. 

“Behaviour can be changed, not just by creating the knowledge, but also by actually demonstrating it and by reinforcing the messages across the landscape,” said Ogunmoyela.

In the marketplace, food quality assurance needs to be improved, in particular, for most sensitive products, like milk, cheese and meat, in countries that have warm climates or even tropical conditions.  

Vendors selling their produce at the open-air Gosa Market in Abuja, Nigeria. The infrastructure in traditional markets can expose products to the weather elements, which highlights the need for greater food quality assurance and basic infrastructure.

“We have a golden opportunity this year to transform our agri-food system to be safer, to be more inclusive, more resilient, and to really feed the whole population with nutritious and safe food,” said Ismahane Elouafi, FAO Chief Scientist, speaking separately, at a joint press briefing with WHO on World Food Safety Day, in which WHO released a new handbook to help countries assess their own foodborne disease burden, and identify food safety system needs. 

“Food should sustain and support human health, not harm it,” said Dr Tedros Adhanom Ghebreyesus, WHO Director General, at the briefing. “When food safety is improved, we reduce hunger, malnutrition and infant mortality; children miss fewer days at school; adults increase their productivity; and the strain on health systems is reduced.”

Image Credits: Michael Casmir, Pierce Mill Media, Pierce Mill Media, Michael Casmir/Pierce Mill Media, Deutsche Welle, GAIN, Madina Maishanu , Pierce Mill Media.

Greenpeace Switzerland activists project messages in various languages outside the WTO building in Geneva in support of the TRIPS waiver.

While European Union (EU) member states continue to oppose a waiver on intellectual property rights for COVID-19 vaccines and medicines, they may soon find themselves at odds with the European Parliament, which is expected to pass a resolution in support of the waiver on Wednesday.

Negotiations on the controversial waiver proposal, co-sponsored by India and South Africa, will resume again on Tuesday at the World Trade Organization’s (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council. 

The waiver would extend to patents, copyright, industrial designs, and “trade secrets” related to all COVID-19 “products and technologies”.  According to an amended version of the initiative, it would be time-limited to three years – with WTO  review annually.

The proposal has met with continued opposition from the European Union (the European Council and the European Commission) which tabled its own counter-proposal at the TRIPS council last week.  In contrast to the blanket waiver, the EU initiative would continue to rely upon the use of existing IP exceptions to allow countries to produce COVID-19 vaccines and medicines under compulsory licenses as needed. 

Last month, Ambassador Xolelwa Mlumbi-Peter, South Africa’s Permanent Representative to the WTO and co-sponsor of the proposal, condemned the “circular discussion” on the waiver proposal – which was made eight months ago.

Ambassador Xolelwa Mlumbi-Peter, South Africa’s Permanent Representative to the WTO

Her Indian counterpart and co-sponsor, Ambassador Brajendra Navnit, says that waiver opponents have been using “delaying tactics” by  “changing goalposts” to raise new problems once their earlier concerns had been addressed.

Groundswell of European Parliamentary Support 

However, a groundswell of support for the broader waiver initiative is emerging among European parliamentarians.  The draft resolution due to go to the plenary on Wednesday calls for “a temporary TRIPS waiver for COVID-19 vaccines and related health technologies, and for the EU to actively participate in text-based negotiations at the World Trade Organization (WTO) to achieve this”.

A motion to approve the resolution already passed by a comfortable majority in the European Parliament’s Committee on International Trade on 19 May, and is widely expected to be carried by the plenary.

Proponents of the waiver say it is an essential tool to stimulate more vaccine production in countries and manufacturing sites that have idle capacity – and thus get 11 billion vaccines made and distributed as fast as possible to immunise 70% of the world’s adults against SARS-CoV2.

Vaccine dose-sharing has so far only yielded 200-million doses at most – and on Monday WHO launched another urgent appeal to G7 leaders, meeting this coming weekend, for donations of another 100 million doses now, and 250 million doses by September. 

The net result is that while the US and the EU are moving to normalise their societies as they mass-vaccinate, poor countries in Africa and Latin America, which lack vaccines, are facing third and fourth waves of the pandemic.  

In Latin America, the rate of new COVID cases is now three times that of India – and these swelling numbers could also give rise to more virus variants in a region that has already seen significant variants of concern emerge in countries like Brazil from uncontrolled infection spread.

At the same time, a number of reputable vaccine manufacturers – notably in Indonesia and Bangladesh – have stated that they have the capacity to produce COVID-19 vaccines – but cannot because none of the pharma companies that have successfully developed a COVID vaccine have signed them onto manufacturing deals. 

Compulsory Licenses Are a ‘Legitimate Tool’

Even so, the EU remains resolute in its opposition to the TRIPS waiver on COVID-19 products and technologies – despite the groundswell of support the waiver initiative has gained among 60 WTO members, including a US endorsement of a waiver on vaccine-related IP.

Last Friday, the EU made public its counter-offer to the waiver that proposed that WTO actions focus on three very modest fixes: 

  • Lifting cross-border trade restrictions on COVID-19 vaccines, treatments and components; 
  • Encouraging vaccine producers to voluntarily expand production; 
  • Facilitating the use of compulsory licensing within the TRIPS Agreement.

“Voluntary licenses are the most effective instrument to facilitate the expansion of production and sharing of expertise,” the EU stated.

“Where voluntary cooperation fails, compulsory licenses, whereby a government grants a targeted license allowing a willing producer to make a vaccine without the consent of a patent-holder, are a legitimate tool in the context of a pandemic.” 

Current Rules for Compulsory Licenses Onerous – Critics Say

Free the Vaccine Activists held protests across the US last week calling for wealthy nations to support the TRIPS waiver.

But critics say compulsory licenses designed to satisfy the domestic needs of a country in crisis – are too complicated and onerous for the kind of quick and large-scale global actions needed now to combat the pandemic. 

In particular, medicines or vaccines produced under a compulsory license by one country cannot easily be exported to another country – without the producers’ fulfilling yet another series of detailed conditions that only permit such exports under closely curtailed TRIPS “exceptions”.  

The WTO export restrictions on products manufactured under compulsory licenses bode ill, in particular, for vaccine producers – which use components procured from multiple suppliers, in processes that also may take place in diverse countries – from producing the active biological ingredients to “fill and finish”. 

Moreover, in order to ensure sustainability and even quality control, vaccine producers typically fabricate their products in large volumes for export to multiple countries – something difficult to do under existing TRIPS rules. 

Bolivia’s Compulsory License ‘Test Case’

Bolivia, for instance, is currently involved in a compulsory licensing “test case”.  The Bolivian government is trying to get the Canadian government to issue a compulsory license to the Canadian company Biolyse, so that it can export vaccines to Bolivia and other countries with vaccines. 

Biolyse says it has the capacity to produce 20 million COVID-19 vaccine doses for use by low and middle-income countries like Bolivia – but cannot do so because of IP restrictions.

A number of other manufacturers – notably in Indonesia and Bangladesh – have also indicated that they have the capacity to produce COVID-19 vaccines but cannot because they have not received voluntary licenses from the pharma companies that have successfully developed a COVID vaccines so far. 

Meanwhile, Médecins Sans Frontières (MSF) has documented examples of countries that issued compulsory licenses for domestic production medicines, as already allowed by TRIPS, have faced pressure from wealthier nations.

“Since India issued its first compulsory license on pharmaceutical patents, the US has applied continuous pressure on India to discourage any further compulsory licensing on patented medicines,” according to MSF.

“The US Trade Representative’s annual Special 301 report systematically criticises developing countries who either reform their IP law to include TRIPS flexibilities or make use of compulsory licenses,” MSF elaborated.

“The EU’s annual IP enforcement report also criticises a number of developing countries for compulsory licensing laws and other uses of TRIPS flexibilities. This kind of pressure continued at the peak of the COVID-19 pandemic in April 2020.”

EU Accused of Delaying Text-Based Negotiations

Ursula von der Leyen, President of the European Commission.

Last month, China and Russia voiced support for the waiver, and in a surprise move on 5 May, the US broke ranks with the EU and Japan, announcing its support for text-based negotiations on removing IP and patents for COVID-19 vaccines only – as opposed to “products and technologies” proposed by the waiver.

“The Administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the waiver of those protections for COVID-19 vaccines,” said US Trade Ambassador Katherine Tai. “We will actively participate in text-based negotiations at the WTO needed to make that happen.” 

In the wake of the United States announcement on 5 May that it would support an IP waiver, at least for COVID vaccines, waiver advocates have turned up the heat on the EU, whose member states are now widely perceived as the key remaining barrier to some kind of compromise text on the IP waiver initiative.  They also stress that time is of the essence.  

“In addition to muddying the water and diverting attention, the EU is also hoping that its empty-package compulsory licensing proposals will delay text-based negotiations of a waiver agreement so long that implementing the waiver would be economically impractical for alternative producers and countries,” said Professor Brook Baker, Senior Policy Analyst for Health GAP.

‘Necessary and Proportionate’ 

In an pre-print paper, London School of Economics Associate Professor of Intellectual Property Law Siva Thambisetty and colleagues argue that the TRIPS waiver “is a necessary and proportionate legal measure for clearing intellectual property (IP) barriers in a direct, consistent and efficient fashion, enabling the freedom to operate for more companies to produce COVID-19 vaccines and other health technologies without the fear of infringing another party’s IP rights and the attendant threat of litigation”.

“The phenomenon of COVID-19 ‘vaccine nationalism’ has brought into sharp relief the misalignment of current legal and financial incentives to produce and distribute vaccines equitably,” they argue. 

“The crisis further demonstrates the failure of high-income countries (HICs) to realise the promise they made at the time of the TRIPS negotiations in 1994, that by agreeing to the terms of TRIPS, lower and middle-income countries (LMICs) would benefit from technology transfer and the building of productive capacity.”

Widening Support in Global Health Community 

Free the Vaccine activists in San Francisco call on Japan to support the TRIPS waiver

Broader recognition of the failure has also helped drive a series of high-level expressions of support for the waiver proposal from the mainstream global health community including the Bill and Melinda Gates Foundation. 

Even WTO Director-General Dr Ngozi Okonjo-Iweala has stressed the need to “get to a conclusion on this [TRIPS waiver] debate, promote technology transfer and know-how to get lasting increases in production capacity”. 

Whether the next two days of talks in the TRIPS Council go in circles yet again or make progress towards text-based negotiations depends largely on waiver opponents – most notably, the EU, Japan and Brazil.

Meanwhile, the easiest way for vaccine manufacturers to pre-empt the “threat” of the waiver would be for developed countries to massively share existing vaccine doses – and for manufacturers to pledge more production to the World Health Organization’s COVAX global vaccine facility. Calls for both were issued again on Monday by WHO Director General Dr Tedros Adhanom Ghebreyesus.  

Tedros also called upon pharmaceutical companies to join the WHO’s COVID-19 Technology Access Pool (C-TAP) and Technology Transfer Hub, sharing their know-how voluntarily and entering into licensing agreements with other global manufacturers to speed up vaccine production and access. 

With or Without Waiver – WHO Pushes Ahead on Vaccine Technology Transfers 

Meanwhile, said Tedros at Monday’s WHO press briefing, WHO is also moving ahead on measures that aim to build longer-term capacity for technology transfer to developing countries, including an “mRNA Vaccine Technology Transfer Hub”. 

“Two months ago, WHO also issued a call for expressions of interest to establish an mRNA technology transfer hub to facilitate increased global production of mRNA vaccines,” said Tedros, who added that a technical review of expressions of interest from companies interested in transferring their technology, and countries wanting to receive the technology was being conducted.

“We continue to call on companies with mRNA technology to share it through the COVID 19 technology access pool. The result can be a win-win for both the owner of the know-how as well as for public health,” added Tedros. 

“The biggest barrier to ending the pandemic remains sharing: of doses, of resources, of technology.”

 

Image Credits: Maxime Gautier/ Greenpeace, Twitter – Ursula von der Leyen.

WHO’s Director General Dr Tedros Adhanom Ghebryesus called on leaders of the  G7 Group of the world’s most industrialized nations to share at least 100 million more COVID-19 vaccine doses with low- and middle-income countries in June and July and 250 million doses by September. 

His appeal, at a WHO press conference Monday,  added to the growing chorus of voices being directed at G7 leaders to step up donations of vaccines and funding – when they meet this coming weekend in Cornwall, England for the first face-to-face meeting since the pandemic began.

See 100 Former World Leaders Urge G& to Donate $US 44 Billion

“Increasingly we are seeing a two track pandemic,” Tedros said, adding that the inequitable distribution of vaccines is “a threat to all nations” because it ‘increases the chances of a variant emerging that renders the vaccine less effective.” 

He also called upon vaccine manufacturers to commit 50% of any new volumes of vaccines produced to the WHO co-sponsored global COVAX facility – or at the least give COVAX the first right of refusal to those new vaccine volumes. 

Amidst Global Declines in Cases – Latin America Remains Global Hotspot   

The G7 meeting takes place with some good news on the horizon. For the sixth week in a row, the world has witnessed sharp declines in new COVID cases. 

However, “a mixed picture” remains with more deaths reported last week than the week previous, in three WHO regions – Latin America, the African region and the Western Pacific, Tedros said.  

Latin America, in particular, remained a global hotspot – with yet another wave of rising COVID cases over the past month.  That wave hit a weekend peak of about 300 cases per million people. That is currently more than three times the number of new cases being seen by hard-hit India, five times that of Europe and six times higher than the global average. 

“We continue to see encouraging signs in the trajectory of the pandemic,” Tedros said, “However we still see a mixed picture around the world.  Many countries still face an extremely dangerous situation while some of those with the highest vaccination rates are starting to talk about ending restrictions.

“Six months since the first vaccines were administered, high income countries have administered almost 44% of the world’s vaccines, while low income countries have administered just 0.4%. 

“But the frustrating thing about this situation is that it hasn’t changed; and inequitable vaccination is a threat to all nations, not just those with the fewest vaccines. 

At the World Health Assembly I call for a massive global effort to vaccinate at least 10% of the population of all countries by September, and at least 30% by the end of the year.  To reach those targets we need an additional 250 million doses by the September.  And we need 100 million doses in June and July.  The G7 nations have the power to meet these targets, and I am calling on the G7 not to just commit to sharing doses, but to commit to sharing them in June and July. 

Quest for Origins of SARS-CoV2 Virus 

Dr Mike Ryan, WHO Executive Director of WHO’s Health Emergencies Programme.

Regarding the ongoing quest to identify the source of the SARS-CoV2 virus, WHO officials said that the Organization lacks any mandate to compel member states such as China to disclose data or information that Beijing may be withholding. 

Within the context of the WHO inquiry, the entire investigation must be conducted on a “consensus” basis with member states, stressed Dr Mike Ryan, Executive Director of WHO’s Health Emergencies programme. 

“WHO does not have the power to investigate or enter countries without the express permission and cooperation of that country. That is the basis on which the organization is established in its constitution, it’s a member state organization. And that says 194 Member States agree on the rules,” Ryan said, in response to a reporter’s question about whether WHO would follow up on allegations that China has suppressed valuable epidemiological about the early case trial in Wuhan, as well as laboratory data on related horseshoe bat viruses. 

“So from that perspective, WHO has no powers to compel.  What we do is we work through cooperation, we work through consensus, and that has worked extremely well for WHO in polio eradication, in smallpox eradication, in dealing with multiple outbreaks and emergencies that occur every year.  We get remarkable cooperation from most of the vast majority of countries in engaging in outbreak investigations and outbreak response in emergency response.” 

While acknowledging it is “very, very important that the world understands what the origins of SARS-CoV2 was, ….it’s not always easy to determine that,” Ryan added. “For many other diseases it has taken years of study.”

In that vein, he said that the WHO-convened team of experts that are studying the origins of the virus – and which in March issued their first report of intial findings – would propose the necessary Phase 2 studies “to take our understanding and knowledge to the next level.” The preliminary findings of the first report had stated that the infection of humans was “very likely” due to food-borne exposures to wild or domesticated animals, or animal products, infected with the virus. 

The same report concluded that it was “extremely unlikely” that the infection originated in the escape of the virus from a laboratory, such as the Wuhan Institute of Virology, which was studying closely related bat viruses.

That provoked an outcry among scientific critics who said that the Chinese government had suppressed and concealed vital data and databases, and thus the WHO-convened group lacked a real factual basis for ruling out the lab escape possibility. 

WHO’s Director General Tedros later acknowledged that the laboratory escape hypothesis had not been adequately explored in the initial investigtion phase.  But WHO so far has not outlined a way forward on the investigation, despite recent diplomatic pressures from the United States and other member states – including a US announcement of its own investigation during the 24 May-June 1 World Health Assembly. 

 

Image Credits: WHO.

President of Uganda Yoweri Museveni addressing the nation

Uganda has imposed more stringent measures to control COVID-19 transmission after it recorded over 1000 new cases per day on 2 June – its highest tally ever, mostly among people aged between 20 and 39 years.

On Sunday, President Yoweri Museveni instituted a 42-day lockdown during which time all schools and institutions of higher learning will be closed. Teachers will also have to be fully vaccinated before they are accepted back to the classrooms.

Since March, Uganda’s education institutions have been a major source of COVID-19 infections with a total of 948 reported cases in 43 schools from 22 districts. 

Over 60% of cases have come from Kampala, Gulu, Masaka and Oyam districts. 

“We believe this number is much higher, only that most schools are not reporting. They are hiding because they don’t want to be closed and most of them want to get money,” said Museveni. 

The increased COVID-19 infections in schools has been attributed to poor compliance with behavioural guidelines such as mask-wearing, inadequate sanitation facilities and overcrowding.

Communal gatherings of over 20 people, including at places of worship, conferences and cultural gatherings, have also been suspended for the next 42 days.

However, the Cabinet, legislature, and the judiciary are allowed, as are small gatherings under 20 people and agriculture activities, factories, construction, shopping malls, food markets and supermarkets. But all have to close by 7pm.

Test Positivity Reaches 18%

Last Friday, the Ministry of Health’s testing results indicated 1,259 new cases out of 7,289 samples tested and nine deaths. 

Uganda’s cumulative confirmed cases are 52,935 and deaths are up to 383. Active cases on admission at health facilities are 634 and the test positivity rate has increased to 18.1%.  

“A test positivity above 10% is a cause for concern especially in a country where testing is reasonably being done,” said the World Health Organisation regional director for Africa, Dr Matshidiso Moeti. 

Museveni said this situation is beginning to stress the health facilities, with pressure of available  beds and oxygen in hospitals.

“The intensity of the illness and severity among the COVID-19 patients is higher than what we experienced in the previous phase,” said Museveni about the second wave. He encouraged people to work from home with only 30% of the staff who work in offices allowed with physical presence.  

Inter-district movement has also been suspended except for tourist vehicles and cargo trucks that have to carry only two people.

Museveni said all travelers have to undergo mandatory COVID-19 testing because some who would come into the country with purported negative PCR test results were tested positive.

To date, Uganda has confirmed a total of 126 cases from travelers coming in through Entebbe International airport out of 4,327 travelers entering the country since the pandemic started. 

 

Health Director General Henry Mwebesa

Meanwhile, the country has used 748,676 AstraZeneca vaccines out of 964,000 available, with 712,681 people having their first dose and 35,995 people having received both doses.

The country received 864,000 doses from COVAX in March and 100,000 as a donation from the Indian government.

Museveni said the government is committed to vaccinating all the 21.9 million eligible Ugandans, starting with the priority groups of 4.8 million people. 

The country is also trying to avoid wastage of COVID-19 vaccines by reassigning vaccines from low to high absorption areas. Malawi destroyed vaccines last week due to expiration.

Districts that have a below 50 percent uptake of COVID-19 vaccines in Uganda will have them withdrawn and redeployed elsewhere unless they act immediately, the Ministry of health has announced. The vaccines are due to expire by 10 July.

Vaccines to be Redeployed

Health Director General Henry Mwebesa says the withdrawn vaccines will be redeployed to the  Kampala Metropolitan Area where the infection rate and uptake are high.

“Take note that there will be penalties for those that waste vaccines or allow vaccines in their possession to expire yet these are very expensive life saving vaccines,” warned Mwebasa.

When the vaccines were delivered, the districts were given three months to vaccinate vulnerable groups including health workers, teachers, security personnel and anyone between 18 and 50 years with comorbidities.

According to some district leaders, some places have been unable to roll out vaccinations properly as they are under-staffed or newly created with inefficient management systems.

“Most of these districts have valid reasons for the low absorption. Ultimately, they have no capacity to translate policy into action,” said Alfred Driwale, the manager of the Uganda National Expanded Programme on Immunization (UNEPI) at the Ministry of Health.

Meanwhile, Museveni warned the public to either comply or face a total lockdown and fines: “Failure to observe the stated directives within a week, I will direct a total lockdown. Those who do not care for the health of Ugandans will pay financially.”

 

Boris Johnson, Prime Minister of the UK, at a press conference in mid-May.

Boris Johnson, UK’s Prime Minister, called upon the leaders of high-income countries to commit to vaccinating the world by 2022 – ahead of Friday’s Group of 7 (G7) meeting of most industrialised nations. 

His appeal came as 230 prominent figures, including 100 former prime ministers, presidents, and foreign ministers penned a letter urging G7 nations to pay two-thirds of the US$66 billion needed to vaccinate low-income countries. 

The wealthy nations must make 2021 “a turning point in global cooperation,” said the letter. 

Johnson will host the first in-person G7 summit in two years in Cornwall, with the leaders of the United States, Japan, Germany, France, Italy and Canada. 

“I’m calling on my fellow G7 leaders to join us to end this terrible pandemic and pledge we will never allow the devastation wreaked by coronavirus to happen again,” said Johnson in a statement on Saturday. 

“Vaccinating the world by the end of next year would be the single greatest feat in medical history,” he added. 

World Leaders call on G7 to Fund Global Vaccination Effort

The open letter to the G7, championed by 100 former presidents and heads of state, said that the G7 should “lead the way” by paying US$43 billion to the Access to COVID-19 Tools (ACT) Accelerator. It is estimated that ACT-A will need US$66 billion over two years to fully fund the global vaccination effort. 

“For the G7 to pay is not charity, it is self-protection to stop the disease spreading, mutating and returning to threaten all of us,” said Gordon Brown, former UK Premier and UN Special Envoy for Global Education. 

“Costing just 30 pence per person per week in the UK is a small price to pay for the best insurance policy in the world. Savings from vaccinations are set to reach around US$9 trillion by 2025,” Brown said. 

Other signatories of the letter also include former UK Prime Minister Tony Blair, former UN Secretary General Ban-Ki Moon, former Prime Minister of Korea Han Seung-soo, former President of Nigeria Olusegun Obasanjo, and former President of Ghana John Mahama. 

Public Support for G7 Investment in Vaccine Rollout and Sharing of Doses and Know-how

The plea coincided with a poll conducted by Save the Children, which found that support for G7 countries paying for global vaccinations was overwhelming among respondents across the G7’s European and American members. Japan, the G7’s only Asian member, was not included in the poll. 

In the UK, 79% of respondents were in favour of such a policy, 76% supported it in the US, 73% in Canada, 71% in Germany, and 63% in France.

Some 80% of the respondents backed both the sharing of doses and intellectual property for vaccines by G7 countries. 

“When it comes to vaccine justice what stands out is that people of different ages, in different locations and with different backgrounds are united,” said Bidisha Pillai, Global Policy, Advocacy and Campaigns Director for Save the Children. 

“They want the G7 to make the world safe again. Their publics will not accept anything less than a serious and fully-funded plan to crack the global COVID-crisis,” Pillai said. 

Commitments to Share Doses

Several G7 countries have announced plans to share doses, with the US pledging to donate 80 million surplus doses beginning in late June and Germany, France and Italy promising to share a total of 75 million doses. 

The UK, on the other hand, has committed to donating surplus doses but has not announced how many will be released or when. It is expected that Johnson will announce more details at the G7 summit. 

The UK has secured access to over 400 million jabs for a population of 66.6 million. Some 59.4% of the population has received at least one dose of a vaccine.

More than 85% of doses have been administered in high- and upper-middle-income countries, while 0.3% have been administered in low-income countries.

The comparison between vaccination rates in G7 countries and seven low-income countries with some of the world’s lowest vaccination rates is a stark visual representation of the inequity in the global vaccine rollout.

Sharing Vaccine Doses Versus Children’s Vaccination 

The stepped up pressure to share doses also comes at a time when the United States and European countries are beginning to vaccinate children and adolescents as young as 12, following regulatory approval of the Pfizer mRNA vaccine as safe for younger age groups. 

WHO’s Director General Dr Tedros has urged countries to postpone vaccinating children if it comes at the expense of vaccinating high risk groups such as older people and health workers in low- and middle-income countries.   

“I understand why some countries want to vaccinate their children and adolescents, but right now I urge them to reconsider and to instead donate vaccines to COVAX,” said Tedros during a press briefing in late May.

“In low- and middle-income countries, COVID-19 vaccine supply has not been enough to even immunise healthcare workers, and hospitals are being inundated with people that need lifesaving care urgently,” Tedros added.

Dr Tedros Adhanom Ghebreyesus, WHO Director General, at a press briefing in late May.

Other critics, however, have said that the issue is not so simple since some children have pre-existing conditions that require vaccination, and some high-income countries with traditionally high COVID rates may need to vaccinate children to advance herd immunity that also curbs the risks of variant spread.

A countermeasure to the emergence of new variants is to “get as many people within a population vaccinated and protected so the virus has less space to grow, less space to spread,” Anita Shet, Director of Child Health at the International Vaccine Access Center at Johns Hopkins Bloomberg School of Public Health, told Politico.

“It means that we need to get vaccines into most of the population regardless of age,” Shet added.

In addition, the Pfizer/BioNTech and Moderna vaccines are the main ones to have been approved in the United States, the United Kingdom or Europe for use among children aged 12-15 – and that vaccine has limited utility in many low-income countries due to its ultra-cold storage requirements. 

Image Credits: Telegraph, WHO.